Related Experiment Video

Updated: Aug 11, 2026

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

Stress signaling and Myc downregulation: implications for cancer

Zhongdong Huang1

  • 1The George Williams Hooper Foundation, University of California, San Francisco, 94143-0522, USA. huangzd@itsa.ucsf.edu

Cell Cycle (Georgetown, Tex.)
|March 27, 2004
PubMed

Insights

The stress-responsive Pak2 pathway phosphorylates Myc, inhibiting its cancer-driving activity and promoting its degradation. This suggests targeting Pak2 could be a therapeutic strategy against Myc-induced cancers.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Signaling

Background:

  • The transcription factor Myc is crucial for cell proliferation and oncogenic transformation.
  • Myc functions by forming a complex with its partner Max and binding to target gene regulatory DNA sequences.
  • Dysregulation of Myc is implicated in various cancers, making it a significant target for therapeutic intervention.

Purpose of the Study:

  • To investigate the role of the stress-responsive protein kinase Pak2 signaling pathway in regulating Myc activity.
  • To elucidate the mechanism by which Pak2 affects Myc function and oncogenic transformation.
  • To explore the potential of targeting Pak2 as a therapeutic strategy for Myc-driven neoplasia.

Main Methods:

  • Investigated the interaction between Pak2 and Myc using biochemical assays.
  • Analyzed the effect of Pak2-mediated phosphorylation on Myc's DNA-binding activity and gene activation.
  • Assessed the impact of Pak2 signaling on Myc protein stability and cellular proliferation/transformation.
  • Examined the therapeutic potential of Pak2 activation in preclinical cancer models.

Main Results:

  • Demonstrated that Pak2 phosphorylates Myc, thereby inhibiting the formation of the Myc/Max/DNA complex.
  • Showed that Pak2-mediated phosphorylation of Myc leads to loss of gene activation, reduced proliferation, and impaired cellular transformation.
  • Confirmed that phosphorylation by Pak2 promotes the degradation of the Myc protein.
  • Indicated that activation of Pak2 signaling can effectively block Myc-induced oncogenic transformation.

Conclusions:

  • The Pak2 signaling pathway acts as a negative regulator of Myc.
  • Pak2-induced Myc phosphorylation disrupts Myc's oncogenic functions and promotes its degradation.
  • Targeting stress signaling pathways like Pak2 presents a promising therapeutic avenue for combating Myc-driven cancers.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...